When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ADAP - Why Adaptimmune Therapeutics Stock Is Spiking Today
Adaptimmune Therapeutics plc
Adaptimmune Therapeutics (NASDAQ: ADAP) , a clinical-stage biotech, saw its shares spike by as much as 10% in early morning trading Monday. Although the stock has cooled off somewhat in afternoon trading, its shares were still up by a healthy 8% as of 12:52 p.m. EDT Monday.
Adaptimmune's stock appears to be moving northward today in response to Pfizer 's $2.26 billion buyout of oncology specialist Trillium Therapeutics . In short, investors are apparently on the hunt for the next buyout play in oncology.